Arab Israeli Conflict
Hi Tech News
vaccine shot 88.
(photo credit: )
As you can imagine, more people are reading The Jerusalem Post than ever before.
Nevertheless, traditional business models are no longer sustainable and high-quality publications,
like ours, are being forced to look for new ways to keep going. Unlike many other news organizations,
we have not put up a paywall. We want to keep our journalism open
and accessible and be able to keep providing you with news
and analyses from the frontlines of Israel, the Middle East and the Jewish World.
As one of our loyal readers, we ask you to be our partner.
For $5 a month you will receive access to the following:
Help us grow and continue telling Israel’s story to the world.
Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief
The American and European health authorities have recommended that all infants be protected against rotavirus with a new, apparently safer version of an attenuated (live but weakened) viral vaccine.
Seven years ago, a previous version made by the Wyeth company was suddenly withdrawn due to reported complications. In the US, a federal advisory committee of the Food and Drug Administration made the recommendation of three doses of the oral vaccine for nearly every child at age two, four and six months after the FDA formally approved it in February and some American pediatricians have received supplies of it. The vaccine is effective in preventing gastroenteritis, which can cause serious complications in children.
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>
By UNIVERSITY OF MICHIGAN HEALTH SYSTEM
By AMERICAN PHYSIOLOGICAL SOCIETY
By UNIVERSITY OF CHICAGO MEDICAL CENTER
By JPOST.COM STAFF AND JUDY SIEGEL-ITZKOVICH
By ANNE GRANT, SPECIAL TO THE JERUSALEM POST
Please insert a valid email address